ArticleOncotarget2016
Identification of KLK10 as a therapeutic target to reverse trastuzumab resistance in breast cancer.
Zhuo Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleOncotarget2016
Zhuo Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.